TMEDETF / FundT. Rowe Price Health Care ETF
Verdicts genuinely change. Free email alert the moment TMED's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
T. Rowe Price Health Care ETF ETF · T. Rowe Price Exchange-Traded Funds, Inc.
102 holdings · as of 2026-06-30 (4.6 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
NON-COMPLIANT 28.94% of portfolio weight is in non-compliant holdings, over the 5% threshold.
102 holdings, 70 matched (90% of weight). Portfolio as of 2026-06-30, filed 2026-08-27. Source: SEC Form N-PORT.
2.10% of this portfolio’s income is non-permissible — weighted across holdings, computed over 82% of portfolio weight (54 of 102 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
61.6% compliant 0.0% questionable 28.9% non-compliant 9.5% unscreened
All holdings (102)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY ELI LILLY & CO | COMPLIANT | 16.71% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 6.52% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| GILD GILEAD SCIENCES INC | COMPLIANT | 4.44% | AAOIFI12.6% Usmani51.0% Dow Jones Islamic17.6% S&P Shariah20.4% MSCI Islamic51.0% MSCI Islamic M-Series20.4% FTSE Shariah51.0% |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 4.11% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| DHR DANAHER CORP | COMPLIANT | 2.96% | AAOIFI16.4% Usmani28.4% Dow Jones Islamic18.0% S&P Shariah16.8% MSCI Islamic28.4% MSCI Islamic M-Series16.8% FTSE Shariah28.4% |
| COR CENCORA INC | COMPLIANT | 2.75% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| A AGILENT TECHNOLOGIES INC | COMPLIANT | 2.61% | AAOIFI8.1% Usmani28.3% Dow Jones Islamic10.6% S&P Shariah10.4% MSCI Islamic28.3% MSCI Islamic M-Series10.4% FTSE Shariah28.3% |
| ALNY ALNYLAM PHARMACEUTICALS INC | COMPLIANT | 2.60% | AAOIFI1.1% Usmani3.1% Dow Jones Islamic0.6% S&P Shariah0.7% MSCI Islamic3.1% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| ISRG INTUITIVE SURGICAL INC | COMPLIANT | 2.43% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| PODD INSULET CORP | COMPLIANT | 2.38% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| SYK STRYKER CORP | COMPLIANT | 2.22% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| DYN DYNE THERAPEUTICS INC | NON_COMPLIANT | 2.03% | AAOIFI7.0% Usmani17.7% Dow Jones Islamic9.1% S&P Shariah9.1% MSCI Islamic17.7% MSCI Islamic M-Series9.1% FTSE Shariah16.2% |
| ELAN ELANCO ANIMAL HEALTH INC | NON_COMPLIANT | 1.91% | AAOIFI26.7% Usmani26.4% Dow Jones Islamic37.4% S&P Shariah40.5% MSCI Islamic26.4% MSCI Islamic M-Series40.5% FTSE Shariah26.4% |
| PFE PFIZER INC | NON_COMPLIANT | 1.91% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| CYTK CYTOKINETICS INC | COMPLIANT | 1.69% | AAOIFI7.3% Usmani29.6% Dow Jones Islamic7.7% S&P Shariah8.0% MSCI Islamic29.6% MSCI Islamic M-Series8.0% FTSE Shariah22.9% |
| WAT WATERS CORP | COMPLIANT | 1.68% | AAOIFI10.7% Usmani20.1% Dow Jones Islamic18.0% S&P Shariah19.9% MSCI Islamic20.1% MSCI Islamic M-Series19.9% FTSE Shariah18.6% |
| WST WEST PHARMACEUTICAL SERVICES | COMPLIANT | 1.65% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| ASND ASCENDIS PHARMA A/S | COMPLIANT | 1.60% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BIIB BIOGEN INC | COMPLIANT | 1.55% | AAOIFI19.7% Usmani23.1% Dow Jones Islamic29.8% S&P Shariah27.2% MSCI Islamic23.1% MSCI Islamic M-Series27.2% FTSE Shariah22.7% |
| MCK MCKESSON CORP | COMPLIANT | 1.46% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| DXCM DEXCOM INC | COMPLIANT | 1.46% | AAOIFI4.4% Usmani22.3% Dow Jones Islamic4.6% S&P Shariah4.0% MSCI Islamic21.5% MSCI Islamic M-Series4.0% FTSE Shariah19.9% |
| IMNM IMMUNOME INC | NON_COMPLIANT | 1.38% | AAOIFI0.5% Usmani2.3% Dow Jones Islamic0.7% S&P Shariah0.9% MSCI Islamic2.3% MSCI Islamic M-Series0.9% FTSE Shariah0.0% |
| 22UA.DE BIONTECH SE-ADR | NON_COMPLIANT | 1.29% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| HUM HUMANA INC | NON_COMPLIANT | 1.24% | AAOIFI23.6% Usmani21.8% Dow Jones Islamic36.9% S&P Shariah34.0% MSCI Islamic21.8% MSCI Islamic M-Series34.0% FTSE Shariah21.8% |
| DENALI THERAPEUTICS INC | UNSCREENED | 1.22% | no in-house ratios for this holding |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 1.22% | AAOIFI66.4% Usmani29.2% Dow Jones Islamic80.4% S&P Shariah85.9% MSCI Islamic29.2% MSCI Islamic M-Series85.9% FTSE Shariah23.5% |
| IDXX IDEXX LABORATORIES INC | COMPLIANT | 1.18% | AAOIFI0.9% Usmani13.5% Dow Jones Islamic1.1% S&P Shariah1.1% MSCI Islamic13.5% MSCI Islamic M-Series1.1% FTSE Shariah10.1% |
| VAXCYTE INC | UNSCREENED | 1.18% | no in-house ratios for this holding |
| MTD METTLER-TOLEDO INTERNATIONAL | COMPLIANT | 0.97% | AAOIFI5.9% Usmani54.8% Dow Jones Islamic7.6% S&P Shariah7.4% MSCI Islamic54.8% MSCI Islamic M-Series7.4% FTSE Shariah54.8% |
| HCA HCA HEALTHCARE INC | NON_COMPLIANT | 0.95% | AAOIFI49.0% Usmani82.6% Dow Jones Islamic56.1% S&P Shariah57.9% MSCI Islamic82.6% MSCI Islamic M-Series57.9% FTSE Shariah79.6% |
| IMTX IMMATICS NV | NON_COMPLIANT | 0.87% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| RGEN REPLIGEN CORP | COMPLIANT | 0.85% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 0.77% | AAOIFI31.9% Usmani24.1% Dow Jones Islamic38.0% S&P Shariah33.6% MSCI Islamic24.1% MSCI Islamic M-Series33.6% FTSE Shariah24.1% |
| SHATTUCK LABS INC | UNSCREENED | 0.76% | no in-house ratios for this holding |
| APOGEE THERAPEUTICS INC | UNSCREENED | 0.75% | no in-house ratios for this holding |
| STATE STREET INS US GO MM FD-IS | UNSCREENED | 0.73% | no in-house ratios for this holding |
| BDX BECTON DICKINSON AND CO | NON_COMPLIANT | 0.72% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | NON_COMPLIANT | 0.66% | AAOIFI9.6% Usmani18.8% Dow Jones Islamic4.7% S&P Shariah3.9% MSCI Islamic18.8% MSCI Islamic M-Series3.9% FTSE Shariah18.5% |
| COO COOPER COS INC/THE | COMPLIANT | 0.65% | AAOIFI21.6% Usmani20.1% Dow Jones Islamic17.1% S&P Shariah15.6% MSCI Islamic20.1% MSCI Islamic M-Series15.6% FTSE Shariah20.1% |
| CABA CABALETTA BIO INC | NON_COMPLIANT | 0.62% | AAOIFI2.0% Usmani6.9% Dow Jones Islamic1.9% S&P Shariah1.3% MSCI Islamic1.4% MSCI Islamic M-Series1.3% FTSE Shariah0.0% |
| CG ONCOLOGY INC | UNSCREENED | 0.62% | no in-house ratios for this holding |
| THC TENET HEALTHCARE CORP | NON_COMPLIANT | 0.56% | AAOIFI63.5% Usmani43.2% Dow Jones Islamic83.2% S&P Shariah95.3% MSCI Islamic43.2% MSCI Islamic M-Series95.3% FTSE Shariah43.2% |
| BCAX BICARA THERAPEUTICS INC | NON_COMPLIANT | 0.53% | AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.2% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ALHC ALIGNMENT HEALTHCARE INC | NON_COMPLIANT | 0.50% | AAOIFI21.1% Usmani25.0% Dow Jones Islamic10.2% S&P Shariah12.3% MSCI Islamic25.0% MSCI Islamic M-Series12.3% FTSE Shariah25.0% |
| SRPT SAREPTA THERAPEUTICS INC | NON_COMPLIANT | 0.47% | AAOIFI43.1% Usmani32.8% Dow Jones Islamic21.4% S&P Shariah14.9% MSCI Islamic32.8% MSCI Islamic M-Series14.9% FTSE Shariah26.6% |
| KYMR KYMERA THERAPEUTICS INC | NON_COMPLIANT | 0.47% | AAOIFI0.7% Usmani4.3% Dow Jones Islamic1.4% S&P Shariah1.8% MSCI Islamic4.2% MSCI Islamic M-Series1.8% FTSE Shariah0.0% |
| RVTY REVVITY INC | COMPLIANT | 0.45% | AAOIFI19.5% Usmani29.2% Dow Jones Islamic27.4% S&P Shariah26.6% MSCI Islamic29.2% MSCI Islamic M-Series26.6% FTSE Shariah28.0% |
| ADPT ADAPTIVE BIOTECHNOLOGIES | COMPLIANT | 0.42% | AAOIFI1.6% Usmani10.8% Dow Jones Islamic3.2% S&P Shariah4.3% MSCI Islamic10.8% MSCI Islamic M-Series4.3% FTSE Shariah0.0% |
| MOH MOLINA HEALTHCARE INC | NON_COMPLIANT | 0.41% | AAOIFI36.0% Usmani24.7% Dow Jones Islamic29.7% S&P Shariah24.7% MSCI Islamic23.6% MSCI Islamic M-Series24.7% FTSE Shariah23.6% |
| ONC BEONE MEDICINES LTD-ADR | COMPLIANT | 0.40% | AAOIFI2.8% Usmani12.5% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic12.5% MSCI Islamic M-Series0.3% FTSE Shariah11.7% |
| MPLT MAPLIGHT THERAPEUTICS INC | NON_COMPLIANT | 0.40% | AAOIFI0.3% Usmani0.5% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.5% MSCI Islamic M-Series— FTSE Shariah0.0% |
| 9926.HK AKESO INC | NON_COMPLIANT | 0.39% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| KODIAK SCIENCES INC | UNSCREENED | 0.36% | no in-house ratios for this holding |
| WGS GENEDX HOLDINGS CORP | COMPLIANT | 0.36% | AAOIFI7.1% Usmani27.8% Dow Jones Islamic5.7% S&P Shariah7.7% MSCI Islamic27.8% MSCI Islamic M-Series7.7% FTSE Shariah27.8% |
| DIANTHUS THERAPEUTICS INC | UNSCREENED | 0.35% | no in-house ratios for this holding |
| AVTX AVALO THERAPEUTICS INC | NON_COMPLIANT | 0.34% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.1% MSCI Islamic0.0% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| INCY INCYTE CORP | COMPLIANT | 0.33% | AAOIFI0.0% Usmani0.5% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| 4D MOLECULAR THERAPEUTICS IN | UNSCREENED | 0.32% | no in-house ratios for this holding |
| XENON PHARMACEUTICALS INC | UNSCREENED | 0.32% | no in-house ratios for this holding |
| NVCR NOVOCURE LTD | NON_COMPLIANT | 0.31% | AAOIFI4.4% Usmani7.3% Dow Jones Islamic3.3% S&P Shariah3.3% MSCI Islamic7.3% MSCI Islamic M-Series3.3% FTSE Shariah3.0% |
| EIKN EIKON THERAPEUTICS INC | NON_COMPLIANT | 0.31% | AAOIFI85.5% Usmani35.3% Dow Jones Islamic— S&P Shariah— MSCI Islamic35.3% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ORUKA THERAPEUTICS INC | UNSCREENED | 0.31% | no in-house ratios for this holding |
| STOK STOKE THERAPEUTICS INC | NON_COMPLIANT | 0.31% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| OKUR ONKURE THERAPEUTICS INC | NON_COMPLIANT | 0.30% | AAOIFI0.6% Usmani0.5% Dow Jones Islamic1.9% S&P Shariah1.4% MSCI Islamic0.5% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| STVN STEVANATO GROUP SPA | COMPLIANT | 0.30% | AAOIFI8.2% Usmani17.9% Dow Jones Islamic8.6% S&P Shariah8.0% MSCI Islamic17.9% MSCI Islamic M-Series8.0% FTSE Shariah17.9% |
| SARTORIUS AG | UNSCREENED | 0.30% | no in-house ratios for this holding |
| CAI CARIS LIFE SCIENCES INC | COMPLIANT | 0.29% | AAOIFI7.7% Usmani36.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic36.9% MSCI Islamic M-Series— FTSE Shariah31.3% |
| KARD KARDIGAN INC | NON_COMPLIANT | 0.28% | AAOIFI1.0% Usmani2.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic2.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| CRINETICS PHARMACEUTICALS IN | UNSCREENED | 0.26% | no in-house ratios for this holding |
| GRAL GRAIL INC | NON_COMPLIANT | 0.26% | AAOIFI1.8% Usmani3.1% Dow Jones Islamic3.5% S&P Shariah4.1% MSCI Islamic3.1% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| RCUS ARCUS BIOSCIENCES INC | COMPLIANT | 0.25% | AAOIFI4.0% Usmani12.3% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic12.3% MSCI Islamic M-Series6.2% FTSE Shariah10.9% |
| MAZE MAZE THERAPEUTICS INC | COMPLIANT | 0.21% | AAOIFI3.2% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6% |
| AKTIS ONCOLOGY INC | UNSCREENED | 0.21% | no in-house ratios for this holding |
| ALLO ALLOGENE THERAPEUTICS INC | NON_COMPLIANT | 0.21% | AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0% |
| ORIC ORIC PHARMACEUTICALS INC | COMPLIANT | 0.21% | AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| RAPPORT THERAPEUTICS INC | UNSCREENED | 0.20% | no in-house ratios for this holding |
| AMYLYX PHARMACEUTICALS INC | UNSCREENED | 0.20% | no in-house ratios for this holding |
| Spyre Therapeutics Inc | UNSCREENED | 0.20% | no in-house ratios for this holding |
| DMRA Damora Therapeutics Inc | NON_COMPLIANT | 0.20% | AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.2% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| ENLIVEN THERAPEUTICS INC | UNSCREENED | 0.20% | no in-house ratios for this holding |
| PRCT PROCEPT BIOROBOTICS CORP | COMPLIANT | 0.19% | AAOIFI5.9% Usmani16.2% Dow Jones Islamic3.0% S&P Shariah3.0% MSCI Islamic16.2% MSCI Islamic M-Series3.0% FTSE Shariah10.8% |
| DISC MEDICINE INC | UNSCREENED | 0.19% | no in-house ratios for this holding |
| AVALYN PHARMA INC | UNSCREENED | 0.18% | no in-house ratios for this holding |
| IONS IONIS PHARMACEUTICALS INC | NON_COMPLIANT | 0.18% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| SDGR SCHRODINGER INC | COMPLIANT | 0.16% | AAOIFI6.2% Usmani16.9% Dow Jones Islamic7.6% S&P Shariah6.9% MSCI Islamic16.9% MSCI Islamic M-Series6.9% FTSE Shariah0.0% |
| BLACK DIAMOND THERAPEUTICS I | UNSCREENED | 0.12% | no in-house ratios for this holding |
| ABIVAX SA-ADR | UNSCREENED | 0.12% | no in-house ratios for this holding |
| ERASCA INC | UNSCREENED | 0.12% | no in-house ratios for this holding |
| PSNL PERSONALIS INC | NON_COMPLIANT | 0.12% | AAOIFI2.0% Usmani11.9% Dow Jones Islamic5.7% S&P Shariah8.0% MSCI Islamic11.9% MSCI Islamic M-Series8.0% FTSE Shariah0.0% |
| KPTI KARYOPHARM THERAPEUTICS INC | NON_COMPLIANT | 0.10% | AAOIFI15.4% Usmani5.6% Dow Jones Islamic0.0% S&P Shariah0.1% MSCI Islamic5.6% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| PRME PRIME MEDICINE INC | NON_COMPLIANT | 0.10% | AAOIFI14.3% Usmani51.6% Dow Jones Islamic20.7% S&P Shariah19.0% MSCI Islamic51.6% MSCI Islamic M-Series19.0% FTSE Shariah0.0% |
| IMMUNOVANT INC | UNSCREENED | 0.10% | no in-house ratios for this holding |
| BIOHAVEN LTD | UNSCREENED | 0.09% | no in-house ratios for this holding |
| CRSP CRISPR THERAPEUTICS AG | NON_COMPLIANT | 0.09% | AAOIFI19.9% Usmani30.5% Dow Jones Islamic16.6% S&P Shariah16.4% MSCI Islamic30.5% MSCI Islamic M-Series16.4% FTSE Shariah23.0% |
| N/A | UNSCREENED | 0.08% | no in-house ratios for this holding |
| ANNX ANNEXON INC | COMPLIANT | 0.05% | AAOIFI9.8% Usmani29.2% Dow Jones Islamic46.7% S&P Shariah42.5% MSCI Islamic29.2% MSCI Islamic M-Series42.5% FTSE Shariah19.7% |
| N/A | UNSCREENED | 0.01% | no in-house ratios for this holding |
| N/A | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CENTESSA PHARMACEUTICALS-ADR CVR | UNSCREENED | 0.00% | no in-house ratios for this holding |
| N/A | UNSCREENED | 0.00% | no in-house ratios for this holding |
| APPLIED THERAPEUTICS INC CVR | UNSCREENED | 0.00% | no in-house ratios for this holding |
| METSERA INC CVR | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 38 points of portfolio weight — 68.4% of it passes AAOIFI, 30.2% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 68.4% ratios fail on 18.6% 13.1% not rated under AAOIFI
ratios pass on 39.5% ratios fail on 48.4% 12.2% not rated under Usmani
ratios pass on 63.3% ratios fail on 21.7% 14.9% not rated under Dow Jones Islamic
ratios pass on 64.8% ratios fail on 16.9% 18.3% not rated under S&P Shariah
ratios pass on 30.2% ratios fail on 56.8% 12.9% not rated under MSCI Islamic
ratios pass on 63.4% ratios fail on 21.1% 15.4% not rated under MSCI Islamic M-Series
ratios pass on 39.8% ratios fail on 47.7% 12.5% not rated under FTSE Shariah
70 of 102 listed holdings carry our own per-methodology verdicts (91% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 66 (87% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UNITEDHEALTH GROUP INC | 6.52% |
| DYN DYNE THERAPEUTICS INC | 2.03% |
| ELAN ELANCO ANIMAL HEALTH INC | 1.91% |
| PFE PFIZER INC | 1.91% |
| IMNM IMMUNOME INC | 1.38% |
| 22UA.DE BIONTECH SE-ADR | 1.29% |
| HUM HUMANA INC | 1.24% |
| CVS CVS HEALTH CORP | 1.22% |
| HCA HCA HEALTHCARE INC | 0.95% |
| IMTX IMMATICS NV | 0.87% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
T. Rowe Price Health Care ETF (TMED) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for TMED — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ken Griffin | Citadel Advisors | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 47.50 | NEUTRAL |
| Stochastic %K (14) | 18.70 | BUY |
| CCI (20) | -49.87 | NEUTRAL |
| Williams %R (14) | -81.30 | BUY |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | 0.01 | BUY |
| Momentum (10) | 0.00 | BUY |
| EMA (10) | 34.65 | SELL |
| SMA (10) | 34.72 | SELL |
| EMA (20) | 34.51 | SELL |
| SMA (20) | 34.57 | SELL |
| EMA (30) | 34.42 | SELL |
| SMA (30) | 34.17 | SELL |
| EMA (50) | 34.34 | SELL |
| SMA (50) | 34.12 | SELL |
| EMA (100) | 33.92 | SELL |
| SMA (100) | 34.55 | SELL |
| EMA (200) | 32.41 | BUY |
| SMA (200) | 32.34 | BUY |
About T. Rowe Price Health Care ETF
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 42 |
| 🕐 1H | BEARISH | 27 |
| ⏱ 15-Min | BEARISH | 110 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.